1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. South & Central America Biopharmaceuticals Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. South & Central America Biopharmaceuticals Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. South & Central America Biopharmaceuticals Market Regional Analysis
6.2 South & Central America Biopharmaceuticals Market Revenue 2020-2028 (US$ Billion)
6.3 South & Central America Biopharmaceuticals Market Forecast Analysis
7. South & Central America Biopharmaceuticals Market Analysis – by Product Type
7.1 Monoclonal Antibodies
- 7.1.1 Overview
- 7.1.2 Monoclonal Antibodies: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.2 Recombinant Vaccines
- 7.2.1 Overview
- 7.2.2 Recombinant Vaccines: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.3 Conventional Vaccines
- 7.3.1 Overview
- 7.3.2 Conventional Vaccines: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.4 Recombinant Growth Factors
- 7.4.1 Overview
- 7.4.2 Recombinant Growth Factors: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.5 Purified Proteins
- 7.5.1 Overview
- 7.5.2 Purified Proteins: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.6 Recombinant Proteins
- 7.6.1 Overview
- 7.6.2 Recombinant Proteins: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.7 Recombinant Hormones
- 7.7.1 Overview
- 7.7.2 Recombinant Hormones: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.8 Recombinant Enzymes
- 7.8.1 Overview
- 7.8.2 Recombinant Enzymes: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.9 Cell & Gene Therapies
- 7.9.1 Overview
- 7.9.2 Cell & Gene Therapies: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.10 Cytokines/Interferon/Interleukins
- 7.10.1 Overview
- 7.10.2 Cytokines/Interferon/Interleukins: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8. South & Central America Biopharmaceuticals Market Analysis – by Application
8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.2 Inflammatory & Infectious Disease
- 8.2.1 Overview
- 8.2.2 Inflammatory & Infectious Disease: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.3 Autoimmune Disorders
- 8.3.1 Overview
- 8.3.2 Autoimmune Disorders: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.4 Metabolic Disorders
- 8.4.1 Overview
- 8.4.2 Metabolic Disorders: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.5 Hormonal Disorders & Growth Failure
- 8.5.1 Overview
- 8.5.2 Hormonal Disorders & Growth Failure: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.6 Cardiovascular Diseases
- 8.6.1 Overview
- 8.6.2 Cardiovascular Diseases: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.7 Neurological Diseases
- 8.7.1 Overview
- 8.7.2 Neurological Diseases: South & Central America Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
9. South & Central America Biopharmaceuticals Market – South and Central America Analysis
9.1 Overview
9.2 South and Central America
- 9.2.1 South & Central America Biopharmaceuticals Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 9.2.1.1 South & Central America Biopharmaceuticals Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 Brazil:
South & Central America Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.1.1 Brazil: South & Central America Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.1.2 Brazil: South & Central America Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.2 Argentina:
South & Central America Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.2.1 Argentina: South & Central America Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.2.2 Argentina: South & Central America Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.3 Rest of South and Central America :
South & Central America Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.3.1 Rest of South and Central America : South & Central America Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.3.2 Rest of South and Central America : South & Central America Biopharmaceuticals Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 AbbVie Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AGC Biologics AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Amgen Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bristol-Myers Squibb Co
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Eli Lilly and Co
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Johnson & Johnson
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Lonza Group AG
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 WuXi Biologics Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For South & Central America Biopharmaceuticals Market
